Heartflow, Inc. Common Stock
——
Mentions · last 7 days
124
X counts updated 1h ago
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Healthcare Information Services sits in its cycle right now — and what that implies for $HTFL.
Medical - Healthcare Information Services
No material change from last week — VEEV's 'agentic commercial' CRM framing converts AI from feature to platform pricing, while TEM's oncology AI platform and pharma data licensing confirm AI..
Industry benchmark
11-name peer basket
+30.0%YTD
+29.0%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
-29.6How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
-23.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
-34.3%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
-1.6%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
17.1Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
-42.3%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
80.1%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
0.1Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$64.1M+47.6%83.0%-27.9%$-0.18$-10.5M
Q1 FY26$52.6M+41.3%80.2%-41.9%$-0.32$-32.0M
Q4 FY25$49.1M+40.5%79.5%-36.1%$-0.29$-12.5M
Q3 FY25$46.3M+40.5%76.5%-32.6%$-0.63$-4.2M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$230.1M$229.1M – $230.6M-$0.49-$0.53 – -$0.447
FY27$283.2M$279.6M – $288.1M-$0.27-$0.46 – -$0.077
FY28$343.5M$331.1M – $361.6M$0.04-$0.04 – $0.126
FY29$429.2M$422.7M – $438.5M$0.34$0.33 – $0.354
FY30$501.1M$493.6M – $512.0M$0.60$0.59 – $0.623
In themes
Explore the broader themes this ticker is being talked about under.
More in Medical - Healthcare Information Services
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · last 7 days
No standout posts about $HTFL on X in the last 7 days.